These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
929 related items for PubMed ID: 23881695
1. Topical application of tranexamic acid for the reduction of bleeding. Ker K, Beecher D, Roberts I. Cochrane Database Syst Rev; 2013 Jul 23; (7):CD010562. PubMed ID: 23881695 [Abstract] [Full Text] [Related]
2. Tranexamic acid for reducing mortality in emergency and urgent surgery. Perel P, Ker K, Morales Uribe CH, Roberts I. Cochrane Database Syst Rev; 2013 Jan 31; 2013(1):CD010245. PubMed ID: 23440847 [Abstract] [Full Text] [Related]
3. Tranexamic acid for patients with nasal haemorrhage (epistaxis). Joseph J, Martinez-Devesa P, Bellorini J, Burton MJ. Cochrane Database Syst Rev; 2018 Dec 31; 12(12):CD004328. PubMed ID: 30596479 [Abstract] [Full Text] [Related]
4. Antifibrinolytic drugs for acute traumatic injury. Ker K, Roberts I, Shakur H, Coats TJ. Cochrane Database Syst Rev; 2015 May 09; 2015(5):CD004896. PubMed ID: 25956410 [Abstract] [Full Text] [Related]
5. The efficacy and safety of combined administration of intravenous and topical tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled trials. Xiong H, Liu Y, Zeng Y, Wu Y, Shen B. BMC Musculoskelet Disord; 2018 Sep 07; 19(1):321. PubMed ID: 30193586 [Abstract] [Full Text] [Related]
6. Antifibrinolytic drugs for acute traumatic injury. Roberts I, Shakur H, Ker K, Coats T, CRASH-2 Trial collaborators. Cochrane Database Syst Rev; 2011 Jan 19; (1):CD004896. PubMed ID: 21249666 [Abstract] [Full Text] [Related]
7. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K. Cochrane Database Syst Rev; 2011 Jan 19; (1):CD001886. PubMed ID: 21249650 [Abstract] [Full Text] [Related]
8. Most Effective Regimen of Tranexamic Acid for Reducing Bleeding and Transfusions in Primary Total Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials. Dai WL, Zhou AG, Zhang H, Zhang J. J Knee Surg; 2018 Aug 19; 31(7):654-663. PubMed ID: 28895645 [Abstract] [Full Text] [Related]
14. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K. Cochrane Database Syst Rev; 2011 Mar 16; 2011(3):CD001886. PubMed ID: 21412876 [Abstract] [Full Text] [Related]
15. Antifibrinolytic drugs for acute traumatic injury. Roberts I, Shakur H, Ker K, Coats T, CRASH-2 Trial collaborators. Cochrane Database Syst Rev; 2012 Mar 16; 12():CD004896. PubMed ID: 23418644 [Abstract] [Full Text] [Related]
16. A comparison of combined intravenous and topical administration of tranexamic acid with intravenous tranexamic acid alone for blood loss reduction after total hip arthroplasty: A meta-analysis. Liu X, Liu J, Sun G. Int J Surg; 2017 May 16; 41():34-43. PubMed ID: 28336258 [Abstract] [Full Text] [Related]
20. Combined intravenous and topical tranexamic acid versus intravenous use alone in primary total knee and hip arthroplasty: A meta-analysis of randomized controlled trials. Shang J, Wang H, Zheng B, Rui M, Wang Y. Int J Surg; 2016 Dec 18; 36(Pt A):324-329. PubMed ID: 27856355 [Abstract] [Full Text] [Related] Page: [Next] [New Search]